Regeneron Pharmaceuticals Inc (REGN)
906.54
-0.78
(-0.09%)
USD |
NASDAQ |
Apr 24, 16:00
910.00
+3.46
(+0.38%)
Pre-Market: 09:01
Regeneron Pharmaceuticals Accounts Payable (Quarterly): 606.60M for Dec. 31, 2023
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 606.60M |
September 30, 2023 | 536.60M |
June 30, 2023 | 547.30M |
March 31, 2023 | 599.50M |
December 31, 2022 | 589.20M |
September 30, 2022 | 535.60M |
June 30, 2022 | 534.20M |
March 31, 2022 | 470.30M |
December 31, 2021 | 564.00M |
September 30, 2021 | 427.00M |
June 30, 2021 | 476.00M |
March 31, 2021 | 542.90M |
December 31, 2020 | 475.50M |
September 30, 2020 | 443.10M |
June 30, 2020 | 380.10M |
March 31, 2020 | 347.80M |
December 31, 2019 | 418.10M |
September 30, 2019 | 335.60M |
June 30, 2019 | 244.00M |
March 31, 2019 | 239.60M |
December 31, 2018 | 218.20M |
September 30, 2018 | 172.36M |
June 30, 2018 | 171.91M |
March 31, 2018 | 207.61M |
December 31, 2017 | 178.20M |
Date | Value |
---|---|
September 30, 2017 | 153.95M |
June 30, 2017 | 151.37M |
March 31, 2017 | 141.80M |
December 31, 2016 | 134.98M |
September 30, 2016 | 124.50M |
June 30, 2016 | 101.72M |
March 31, 2016 | 120.60M |
December 31, 2015 | 140.96M |
September 30, 2015 | 106.92M |
June 30, 2015 | 130.02M |
March 31, 2015 | 90.60M |
December 31, 2014 | 99.51M |
September 30, 2014 | 47.34M |
June 30, 2014 | 47.23M |
March 31, 2014 | 32.69M |
December 31, 2013 | 61.94M |
September 30, 2013 | 31.19M |
June 30, 2013 | 24.42M |
March 31, 2013 | 24.73M |
December 31, 2012 | 38.93M |
September 30, 2012 | 21.94M |
June 30, 2012 | 25.67M |
March 31, 2012 | 25.39M |
December 31, 2011 | 27.74M |
September 30, 2011 | 17.31M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
244.00M
Minimum
Jun 2019
606.60M
Maximum
Dec 2023
477.55M
Average
476.00M
Median
Jun 2021
Accounts Payable (Quarterly) Benchmarks
Vertex Pharmaceuticals Inc | 364.90M |
Eli Lilly and Co | 2.599B |
AbbVie Inc | 3.688B |
Amgen Inc | 1.59B |
Pfizer Inc | 6.71B |